122 related articles for article (PubMed ID: 35220218)
1. Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
Yumura M; Nagano T; Jimbo N; Dokuni R; Kiriu T; Tanaka Y; Tachihara M; Itoh T; Maniwa Y; Nishimura Y; Kobayashi K
Anticancer Res; 2022 Mar; 42(3):1289-1294. PubMed ID: 35220218
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.
Kim J; Kim MA; Jee CD; Jung EJ; Kim WH
Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876
[TBL] [Abstract][Full Text] [Related]
3. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Yamaguchi A; Kuwai T; Sudo T; Hadano N; Tashiro H; Taniyama K; Yasuif W
Histol Histopathol; 2022 Mar; 37(3):243-250. PubMed ID: 34821375
[TBL] [Abstract][Full Text] [Related]
4. Annexin A10 Expression Is Associated With Poor Prognosis in Small Bowel Adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Shimizu Y; Sudo T; Tashiro H; Taniyama K; Yasui W
Anticancer Res; 2021 Mar; 41(3):1349-1355. PubMed ID: 33788726
[TBL] [Abstract][Full Text] [Related]
5. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
Wang J; Zhao S; Wang F; Wang J; Zhang Y
Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
[TBL] [Abstract][Full Text] [Related]
8. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
[TBL] [Abstract][Full Text] [Related]
9. Annexin A10 is involved in the induction of pancreatic duodenal homeobox‑1 in gastric cancer tissue, cells and organoids.
Ishikawa A; Sakamoto N; Honma R; Taniyama D; Fukada K; Hattori T; Sentani K; Oue N; Yanagihara K; Tanabe K; Ohdan H; Yasui W
Oncol Rep; 2020 Feb; 43(2):581-590. PubMed ID: 31789399
[TBL] [Abstract][Full Text] [Related]
10. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
[TBL] [Abstract][Full Text] [Related]
12. Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer.
Liu X; Yang M; Guo Y; Lu X
Ir J Med Sci; 2021 Feb; 190(1):59-65. PubMed ID: 32451762
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Hiyoshi Y; Sato Y; Ichinoe M; Nagashio R; Hagiuda D; Kobayashi M; Kusuhara S; Igawa S; Shiomi K; Goshima N; Murakumo Y; Saegusa M; Satoh Y; Masuda N; Naoki K
Thorac Cancer; 2019 Nov; 10(11):2142-2151. PubMed ID: 31583841
[TBL] [Abstract][Full Text] [Related]
14. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Tazawa H; Suzuki T; Tashiro H; Taniyama K; Yasui W
Anticancer Res; 2022 Apr; 42(4):1707-1717. PubMed ID: 35346989
[TBL] [Abstract][Full Text] [Related]
16. Annexin A10 is a marker for the serrated pathway of colorectal carcinoma.
Sajanti SA; Väyrynen JP; Sirniö P; Klintrup K; Mäkelä J; Tuomisto A; Mäkinen MJ
Virchows Arch; 2015 Jan; 466(1):5-12. PubMed ID: 25395067
[TBL] [Abstract][Full Text] [Related]
17. High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma.
Dokuni R; Nagano T; Jimbo N; Sato H; Kiriu T; Yasuda Y; Yamamoto M; Tachihara M; Kobayashi K; Maniwa Y; Nishimura Y
Respir Res; 2020 Dec; 21(1):331. PubMed ID: 33317533
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
Wei T; Zhu X
J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
[TBL] [Abstract][Full Text] [Related]
19. Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
Munksgaard PP; Mansilla F; Brems Eskildsen AS; Fristrup N; Birkenkamp-Demtröder K; Ulhøi BP; Borre M; Agerbæk M; Hermann GG; Orntoft TF; Dyrskjøt L
Br J Cancer; 2011 Oct; 105(9):1379-87. PubMed ID: 21979422
[TBL] [Abstract][Full Text] [Related]
20. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
